Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes

Eur J Immunol. 2002 Jan;32(1):203-12. doi: 10.1002/1521-4141(200201)32:1<203::AID-IMMU203>3.0.CO;2-C.

Abstract

The engagement of antigen receptor can initiate apoptosis of T lymphocytes through the induced expression of Fas ligand (FasL). Forskolin, an activator of the cAMP/PKA pathway, results in antagonism of Fas-dependent, activation-induced cell death (AICD) by suppressed expression of the FasL. We report that forskolin-mediated induction of inducible cAMP early repressor (ICER) correlates with transcriptional attenuation of FasL expression in the AICD model 2B4 T cell hybridoma. ICER is inducible in human peripheral blood CD3(+) T cells, but in CD19(+) B cells, its induction is less responsive to forskolin treatment. Increased expression of ICER correlates with decreased FasL expression in both T and NK cells. ICER binds specifically to the proximal DNA binding site of the nuclear factor of activated T cells (NFAT) in the FasL promoter and in the presence of the minimal NFAT DNA-binding domain, the proximal NFAT motif allows ICER and NFAT to form an NFAT/ICER ternary complex in vitro. Moreover, in the activated 2B4 T cell hybridoma, the proximal NFAT motif participates in the down-regulation of the FasL promoter mediated by ICER. These findings provide further insight into the mechanism involved in cAMP-mediated transcriptional attenuation of FasL expression in T and NK lymphocytes.

MeSH terms

  • Antigens, CD19
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / metabolism
  • Binding Sites
  • Biomarkers
  • CD13 Antigens
  • Cell Line
  • Cells, Cultured
  • Colforsin / pharmacology
  • Cyclic AMP Response Element Modulator
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • DNA-Binding Proteins / physiology*
  • Fas Ligand Protein
  • Gene Expression Regulation*
  • Humans
  • Jurkat Cells
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / metabolism*
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / metabolism
  • Membrane Glycoproteins / genetics*
  • NFATC Transcription Factors
  • Nuclear Proteins*
  • Promoter Regions, Genetic*
  • RNA, Messenger / biosynthesis
  • Repressor Proteins / biosynthesis
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism
  • Repressor Proteins / physiology*
  • T-Lymphocytes / cytology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / metabolism*
  • Transcription Factors / metabolism
  • Transcription, Genetic / drug effects
  • Transcriptional Activation

Substances

  • Antigens, CD19
  • Biomarkers
  • DNA-Binding Proteins
  • FASLG protein, human
  • Fas Ligand Protein
  • Membrane Glycoproteins
  • NFATC Transcription Factors
  • Nuclear Proteins
  • RNA, Messenger
  • Repressor Proteins
  • Transcription Factors
  • Cyclic AMP Response Element Modulator
  • Colforsin
  • CD13 Antigens